Shareholders’ Equity - Schedule of Warrants Activity (Details) - Warrant - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Number of warrants outstanding, beginning balance (in shares)	166,670
Number of warrants outstanding, ending balance (in shares)	166,670	166,670
Weighted Average Exercise Price
Weighted average exercise price, beginning balance (in dollars per share)	$ 17.40
Weighted average exercise price, ending balance (in dollars per share)	$ 17.40	$ 17.40
Share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, outstanding	$ 0	$ 0
Weighted average remaining contractual life (in years)	8 years 7 months 6 days	9 years 7 months 6 days